Clinical Trials Browser

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT05631041 2023-12-22

Effect of Silymarin in Metastatic Colorectal Cancer Patients

Phase 3 Unknown

64 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05081687 2023-10-11

BRAZIL-TNT

Phase 3 Unknown

150 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT00958737 2023-09-29

IDEA

Phase 3 Unknown

2,000 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04262635 2023-08-02

C-CLASSIC

Phase 3 Unknown

80 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03950154 2023-08-01

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Phase 3 Unknown

198 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03391934 2023-04-05

Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

Phase 3 Unknown

234 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05378867 2022-05-18

CRC

Phase 3 Unknown

126 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05362617 2022-05-05

mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy

Phase 3 Unknown

328 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT05327751 2022-04-14

HFS

Phase 3 Unknown

44 enrolled

Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT01150045 2022-03-22

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Phase 3 Unknown

2,527 enrolled 14 charts

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT05187481 2022-01-11

Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer

Phase 3 Unknown

200 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04188145 2021-10-28

BEVAMAINT

Phase 3 Unknown

400 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04917289 2021-06-08

CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients

Phase 3 Unknown

100 enrolled

Gastrointestinal

Neoplastic Cells, Circulating, Colorectal Neoplasms

NCT04912258 2021-06-03

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

Phase 3 Unknown

80 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04690283 2020-12-30

YWPPEOPNCT

Phase 3 Unknown

360 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04525326 2020-08-25

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Phase 3 Unknown

584 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT04509635 2020-08-12

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

Phase 3 Unknown

50 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03448549 2020-03-06

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

Phase 3 Unknown

1,191 enrolled

Gastrointestinal

Patient Compliance, Colorectal Neoplasms

NCT02339116 2020-02-05

TRIBE2

Phase 3 Unknown

654 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02077868 2019-09-10

IMPALA

Phase 3 Unknown

540 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02087475 2019-06-05

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

Phase 3 Unknown

360 enrolled

Gastrointestinal

Neoplasm Metastasis, Neoplasm Recurrence, Local, Colorectal Neoplasms

NCT03716063 2018-10-23

Strengthening the Spleen and Reducing Phlegm Method in Improving Radical Resection Rate of Colorectal Cancer

Phase 3 Unknown

350 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03426371 2018-02-08

Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

Phase 3 Unknown

570 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03303495 2017-10-06

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Phase 3 Unknown

280 enrolled

Gastrointestinal

Digestive System Neoplasms, Gastrointestinal Neoplasms, Intestinal Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT01308086 2017-08-09

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

Phase 3 Unknown

2,000 enrolled

Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT03221608 2017-07-18

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Phase 3 Unknown

300 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT01895257 2017-07-07

Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer

Phase 3 Unknown

162 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT03125161 2017-04-24

Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

Phase 3 Unknown

150 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02316535 2016-09-13

LcACEC

Phase 3 Unknown

710 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02635503 2016-09-02

Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer

Phase 3 Unknown

366 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01465451 2016-08-11

IOCCRC

Phase 3 Unknown

695 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02796820 2016-06-15

Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery

Phase 3 Unknown

230 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02785146 2016-06-08

Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer

Phase 3 Unknown

230 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02748772 2016-04-22

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

Phase 3 Unknown

148 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02744274 2016-04-21

Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study

Phase 3 Unknown

32 enrolled

Gastrointestinal

Hypesthesia, Peripheral Nervous System Diseases, Colorectal Neoplasms

NCT00058474 2016-03-23

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

Phase 3 Unknown

1,608 enrolled

Gastrointestinal

Rectal Neoplasms, Colorectal Neoplasms

NCT02607072 2015-11-18

APREMEC

Phase 3 Unknown

3,000 enrolled

Gastrointestinal

Neoplasm Metastasis, Recurrence, Colorectal Neoplasms

NCT02503150 2015-07-30

Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer

Phase 3 Unknown

480 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT01290783 2015-04-29

FOLF(HA)iri

Phase 3 Unknown

390 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02402972 2015-03-31

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

Phase 3 Unknown

700 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT02248038 2014-09-25

A Multicenter Clinical Trial on Laparoscopic Colorectal Cancer Surgery Compared With Open Surgery

Phase 3 Unknown

1,300 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02125409 2014-05-05

Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action

Phase 3 Unknown

40 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00433927 2014-03-14

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Phase 3 Unknown

568 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT01112046 2014-02-11

Endoscopic Submucosal Dissection Versus Laparoscopic Resection for Early Colorectal Neoplasms

Phase 3 Unknown

124 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT00008281 2014-01-06

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00002692 2013-12-19

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Phase 3 Unknown

312 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00002893 2013-12-19

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Phase 3 Unknown

900 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00021281 2013-12-19

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00617071 2013-12-18

Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants

Phase 3 Unknown

900 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Clinical Trials

ASCOLT

Effect of Silymarin in Metastatic Colorectal Cancer Patients

BRAZIL-TNT

IDEA

C-CLASSIC

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

Comparing Efficacy and Safety of Cetuximab (CinnaGen) Versus Erbitux® (Merck) in Metastatic Colorectal Cancer

CRC

mFOLXOX6 Versus FOLFIRI for Colorectal Patients Recurrence After Oxaplatin Based Adjuvant Chemotherapy

HFS

Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

Effect of Jianpi Huatan Decoction on Advanced Colorectal Cancer

BEVAMAINT

CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients

Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis

YWPPEOPNCT

Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases

Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

TRIBE2

IMPALA

Perioperative FOLFIRI VS Adjuvant FOLFIRI in Resectable Advanced CRC Failed to Oxaliplatin

Strengthening the Spleen and Reducing Phlegm Method in Improving Radical Resection Rate of Colorectal Cancer

Epidermal Growth Factor Receptor (EGFR) Antagonist Chimeric Anti-EGFR Monoclonal Antibody Trial

A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

Clinical Analysis of HIPEC for T4 Colorectal Cancer After Surgery

Comparing HAI-90Y (SIR-spheres)+Chemotx LV5FU2 Versus Chemotx LV5FU2 Alone to Treat Colorectal Cancer

Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

LcACEC

Safety Study of Totally Laparoscopic Resection With Natural Orifice Specimen Extraction (NOSE) for Rectosigmoid Cancer

IOCCRC

Huaier Granule As Adjuvant Therapy for Colorectal Cancer After Radical Surgery

Adjuvant Chemotherapy Combined With Huaier Granule for Treating High-risk Stage II, Stage III Colorectal Cancer

Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical

Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

APREMEC

Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer

FOLF(HA)iri

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

A Multicenter Clinical Trial on Laparoscopic Colorectal Cancer Surgery Compared With Open Surgery

Acetylsalicylic Acid and Colorectal Cancer Prevention: Exploring the Platelet Function of Its Mechanism of Action

5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)

Endoscopic Submucosal Dissection Versus Laparoscopic Resection for Early Colorectal Neoplasms

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants